BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33316386)

  • 1. CAMTA1, a novel antitumor gene, regulates proliferation and the cell cycle in glioma by inhibiting AKT phosphorylation.
    He Z; Yang C; He Y; Gong B; Yin C; Feng J; Chen L; Tang J; Chen Y
    Cell Signal; 2021 Mar; 79():109882. PubMed ID: 33316386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
    Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
    Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA lncCAMTA1 Promotes Proliferation and Cancer Stem Cell-Like Properties of Liver Cancer by Inhibiting CAMTA1.
    Ding LJ; Li Y; Wang SD; Wang XS; Fang F; Wang WY; Lv P; Zhao DH; Wei F; Qi L
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
    Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
    Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma.
    Tian Y; Nan Y; Han L; Zhang A; Wang G; Jia Z; Hao J; Pu P; Zhong Y; Kang C
    Int J Oncol; 2012 Apr; 40(4):1105-12. PubMed ID: 22179124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation.
    Tang Z; Yang G; Wang X; Chen F; Liao Z; Zhang Z; Liu Z; Zeng W; Fang M; Wang W; Sun X; Huo G
    J Neurooncol; 2020 Sep; 149(2):231-242. PubMed ID: 32909117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle-dependent transcriptional regulation of calmodulin-binding transcription activator 1 in neuroblastoma cells.
    Nakatani K; Nishioka J; Itakura T; Nakanishi Y; Horinouchi J; Abe Y; Wada H; Nobori T
    Int J Oncol; 2004 Jun; 24(6):1407-12. PubMed ID: 15138581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAGI3 Suppresses Glioma Cell Proliferation via Upregulation of PTEN Expression.
    Ma Q; Zhang Y; Meng R; Xie KM; Xiong Y; Lin S; He ZL; Tao T; Yang Y; Zhao JZ; He JQ
    Biomed Environ Sci; 2015 Jul; 28(7):502-9. PubMed ID: 26248734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYC-mediated upregulation of PNO1 promotes glioma tumorigenesis by activating THBS1/FAK/Akt signaling.
    Chen X; Guo ZQ; Cao D; Chen Y; Chen J
    Cell Death Dis; 2021 Mar; 12(3):244. PubMed ID: 33664245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.
    Xie D; Yin D; Tong X; O'Kelly J; Mori A; Miller C; Black K; Gui D; Said JW; Koeffler HP
    Cancer Res; 2004 Mar; 64(6):1987-96. PubMed ID: 15026334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WW domain-binding protein 2 acts as an oncogene by modulating the activity of the glycolytic enzyme ENO1 in glioma.
    Chen S; Zhang Y; Wang H; Zeng YY; Li Z; Li ML; Li FF; You J; Zhang ZM; Tzeng CM
    Cell Death Dis; 2018 Mar; 9(3):347. PubMed ID: 29497031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
    FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells.
    Schraivogel D; Weinmann L; Beier D; Tabatabai G; Eichner A; Zhu JY; Anton M; Sixt M; Weller M; Beier CP; Meister G
    EMBO J; 2011 Aug; 30(20):4309-22. PubMed ID: 21857646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells.
    Henrich KO; Bauer T; Schulte J; Ehemann V; Deubzer H; Gogolin S; Muth D; Fischer M; Benner A; König R; Schwab M; Westermann F
    Cancer Res; 2011 Apr; 71(8):3142-51. PubMed ID: 21385898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
    Liao YX; Zhang ZP; Zhao J; Liu JP
    Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas.
    Gao S; Sha Z; Zhou J; Wu Y; Song Y; Li C; Liu X; Zhang T; Yu R
    Cancer Biol Med; 2021 Feb; 18(1):88-104. PubMed ID: 33628587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calmodulin-binding transcription activator 1 (CAMTA1) alleles predispose human episodic memory performance.
    Huentelman MJ; Papassotiropoulos A; Craig DW; Hoerndli FJ; Pearson JV; Huynh KD; Corneveaux J; Hänggi J; Mondadori CR; Buchmann A; Reiman EM; Henke K; de Quervain DJ; Stephan DA
    Hum Mol Genet; 2007 Jun; 16(12):1469-77. PubMed ID: 17470457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.